Literature DB >> 25958045

Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.

Silvia Monticone1, Isabella Castellano2, Karine Versace3, Barbara Lucatello4, Franco Veglio5, Celso E Gomez-Sanchez6, Tracy A Williams5, Paolo Mulatero7.   

Abstract

Adrenal glands removed for unilateral primary aldosteronism (PA) display marked histological heterogeneity. Recently reported somatic mutations in KCNJ5, ATP1A1, ATP2B3 and CACNA1D can partially account for these differences. In this study we aimed at combining phenotypic and genotypic characteristics, integrating genetic and immunohistochemistry correlates in sporadic PA. Seventy-one adrenal glands have been included in the study and analyzed for mutations in KCNJ5, ATP1A1, ATP2B3 and CACNA1D. Histological examination and immunohistochemical staining for CYP11B1 (11β-hydroxylase) and CYP11B2 (aldosterone synthase) were performed on aldosterone-producing adenomas (APAs) and adjacent adrenal cortex. In our cohort, the final histopathological diagnosis was multinodular hyperplasia in 22.5% of the patients and single nodule in 77.5%. Forty-five percent of the removed adrenals displayed extra-APA CYP11B2-positive cell nests (B2-CN). Among adrenal vein sampling parameters the suppression of contralateral adrenal was more frequent and the lateralization index was higher in the subgroup of patients without extra-APA B2-CN compared to the subgroup with extra-APA B2-CN. KCNJ5-mutated APAs were composed mainly of zona fasciculata-like cells with high expression of CYP11B1, while ATP1A1, ATP2B3 and CACNA1D-mutated APAs presented more frequently a zona-glomerulosa-like phenotype with high expression of CYP11B2. We observed a significant inverse correlation between CYP11B2 expression and the size of the nodules and, if CYP11B2 expression was corrected for tumor volume, a significant correlation with plasma aldosterone and aldosterone to renin ratio. Our findings indicate that combination of genotyping and immunohistochemistry improves the final histopathological diagnosis between single nodule and multinodular hyperplasia of the assessed adrenals.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ATP1A1; Aldosterone producing adenoma; CACNA1D; CYP11B1 immunohistochemistry; CYP11B2 immunohistochemistry; KCNJ5

Mesh:

Substances:

Year:  2015        PMID: 25958045      PMCID: PMC4474471          DOI: 10.1016/j.mce.2015.04.022

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  35 in total

1.  Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

Authors:  Sheerazed Boulkroun; Felix Beuschlein; Gian-Paolo Rossi; José-Felipe Golib-Dzib; Evelyn Fischer; Laurence Amar; Paolo Mulatero; Benoit Samson-Couterie; Stefanie Hahner; Marcus Quinkler; Francesco Fallo; Claudio Letizia; Bruno Allolio; Giulio Ceolotto; Maria Verena Cicala; Katharina Lang; Hervé Lefebvre; Livia Lenzini; Carmela Maniero; Silvia Monticone; Maelle Perrocheau; Catia Pilon; Pierre-François Plouin; Nada Rayes; Teresa M Seccia; Franco Veglio; Tracy Ann Williams; Laura Zinnamosca; Franco Mantero; Arndt Benecke; Xavier Jeunemaitre; Martin Reincke; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

2.  Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?

Authors:  T Dekkers; M ter Meer; J W M Lenders; A R M Hermus; L Schultze Kool; J F Langenhuijsen; K Nishimoto; T Ogishima; K Mukai; E A B Azizan; B Tops; J Deinum; B Küsters
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

3.  Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.

Authors:  Elena A B Azizan; Brian Y H Lam; Stephen J Newhouse; Junhua Zhou; Rhoda E Kuc; Jennifer Clarke; Lisa Happerfield; Alison Marker; Gary J Hoffman; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

Review 4.  Dissecting the molecular pathways of primary aldosteronism.

Authors:  Yasuhiro Nakamura; Saulo J A Felizola; Fumitoshi Satoh; Sachiko Konosu-Fukaya; Hironobu Sasano
Journal:  Pathol Int       Date:  2014-10-02       Impact factor: 2.534

5.  Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.

Authors:  Fabio Luiz Fernandes-Rosa; Tracy Ann Williams; Anna Riester; Olivier Steichen; Felix Beuschlein; Sheerazed Boulkroun; Tim M Strom; Silvia Monticone; Laurence Amar; Tchao Meatchi; Franco Mantero; Maria-Verena Cicala; Marcus Quinkler; Francesco Fallo; Bruno Allolio; Giampaolo Bernini; Mauro Maccario; Gilberta Giacchetti; Xavier Jeunemaitre; Paolo Mulatero; Martin Reincke; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2014-05-27       Impact factor: 10.190

6.  Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy.

Authors:  Silvia Monticone; Fumitoshi Satoh; Andrea Viola; Evelyn Fischer; Oliver Vonend; Giampaolo Bernini; Barbara Lucatello; Marcus Quinkler; Vanessa Ronconi; Ryo Morimoto; Masataka Kudo; Christoph Degenhart; Xing Gao; Davide Carrara; Holger S Willenberg; Denis Rossato; Giulio Mengozzi; Anna Riester; Enrico Paci; Yoshitsugu Iwakura; Jacopo Burrello; Mauro Maccario; Gilberta Giacchetti; Franco Veglio; Sadayoshi Ito; Martin Reincke; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2014-08-13       Impact factor: 5.958

7.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism.

Authors:  Silvia Monticone; Fumitoshi Satoh; Gilberta Giacchetti; Andrea Viola; Ryo Morimoto; Masataka Kudo; Yoshitsugu Iwakura; Yoshikiyo Ono; Federica Turchi; Enrico Paci; Franco Veglio; Marco Boscaro; William Rainey; Sadayoshi Ito; Paolo Mulatero
Journal:  Hypertension       Date:  2012-02-13       Impact factor: 10.190

Review 9.  Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.

Authors:  Silvia Monticone; Tobias Else; Paolo Mulatero; Tracy A Williams; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2014-09-18       Impact factor: 4.102

10.  Adrenal vein sampling in primary aldosteronism: towards a standardised protocol.

Authors:  Silvia Monticone; Andrea Viola; Denis Rossato; Franco Veglio; Martin Reincke; Celso Gomez-Sanchez; Paolo Mulatero
Journal:  Lancet Diabetes Endocrinol       Date:  2014-05-13       Impact factor: 32.069

View more
  53 in total

1.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 2.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

3.  Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.

Authors:  Yuhong Yang; Celso E Gomez-Sanchez; Diana Jaquin; Elke Tatjana Aristizabal Prada; Lucie S Meyer; Thomas Knösel; Holger Schneider; Felix Beuschlein; Martin Reincke; Tracy Ann Williams
Journal:  Hypertension       Date:  2019-08-26       Impact factor: 10.190

Review 4.  Hyperaldosteronism: How to Discriminate Among Different Disease Forms?

Authors:  Valentina Crudo; Silvia Monticone; Jacopo Burrello; Fabrizio Buffolo; Martina Tetti; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-02

Review 5.  Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Paul-Emmanuel Vanderriele; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

6.  Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism.

Authors:  Aya T Nanba; Kazutaka Nanba; James B Byrd; James J Shields; Thomas J Giordano; Barbara S Miller; William E Rainey; Richard J Auchus; Adina F Turcu
Journal:  Clin Endocrinol (Oxf)       Date:  2017-09-04       Impact factor: 3.478

7.  In situ metabolomics of aldosterone-producing adenomas.

Authors:  Masanori Murakami; Yara Rhayem; Thomas Kunzke; Na Sun; Annette Feuchtinger; Philippe Ludwig; Tim Matthias Strom; Celso Gomez-Sanchez; Thomas Knösel; Thomas Kirchner; Tracy Ann Williams; Martin Reincke; Axel Karl Walch; Felix Beuschlein
Journal:  JCI Insight       Date:  2019-09-05

8.  Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.

Authors:  Yuto Yamazaki; Kei Omata; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yuzu Adachi; Kazue Ise; Yasuhiro Nakamura; Celso E Gomez-Sanchez; Yukiko Shibahara; Takumi Kitamoto; Tetsuo Nishikawa; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

Review 9.  Primary Aldosteronism: Practical Approach to Diagnosis and Management.

Authors:  James Brian Byrd; Adina F Turcu; Richard J Auchus
Journal:  Circulation       Date:  2018-08-21       Impact factor: 29.690

Review 10.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.